Skip to content

Public FDA record

Z-0700-2013: GreenLight HPS (High Performance System) GreenLight XPS (Xcelerated Performance System) Manufactured by

Recall record Z-0700-2013 for AMS Innovative Center - San Jose. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0700-2013
Company in FDA record
AMS Innovative Center - San Jose
FDA classification date
Jan 22, 2013
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

During electrical recertification testing it was found that the Voltage Scaling Board was non-conforming to the IEC 60601-1-2 standard.

Source facts

Action
AMS sent "NOTICE OF DEVICE FIELD CORRECTIVE ACTION" letters dated December 20, 2012 to all affected customers. The letter identified the product, problem, and actions to be taken by the customers. Contact the firm at 1-408-456-3320 for questions about this notification.
Initiated
2012-12-11
Root cause
Nonconforming Material/Component
Terminated
2014-02-13
Distribution
Worldwide Distribution.
Recall number
Z-0700-2013
Recall status
Terminated
CDRH record ID
115154
FDA classified
2013-01-22
Recall event number
63972

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗